BETHANY RICH: Open Payments
NPI 1518348218 · NORTH BILLERICA, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,892 in 137 payments from 21 companies in 2025. Trend: 2023 $27 · 2024 $766 · 2025 $2,892
Food & beverage: $2,892
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $502 |
| Janssen Biotech, Inc. | 24 | $430 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 22 | $330 |
| ABBVIE INC. | 18 | $308 |
| Phathom Pharmaceuticals, Inc. | 9 | $215 |
| NeurAxis, Inc. | 2 | $146 |
| Regeneron Healthcare Solutions, Inc. | 6 | $118 |
| Madrigal Pharmaceuticals | 4 | $110 |
| Ipsen Biopharmaceuticals, Inc | 4 | $105 |
| Aimmune Therapeutics, Inc. | 3 | $84 |
Products named: ENTYVIO, TREMFYA, XIFAXAN, VOQUEZNA, DUPIXENT, REZDIFFRA, IQIRVO, LINZESS.
Industry payments across MA — which companies pay providers there.
